[1]
S. Dhirawaranan, “Problem issues regarding to COVID-19’s Vaccine under the provision of the Product Liability Act B.E. 2551: Comparative law analysis”, lawhcu, vol. 16, no. 2, pp. 23–29, Apr. 2026.